Abstract-The success of genome-wide association studies and the development of next generation sequencing technology have identified many disease-related common and rare variants. There have been several prediction models suggested using penalized regression or statistical learning methods. However, only a few prediction models are available which use both common and rare variants. The aim of our study is to compare the performance of prediction models systematically by using both common and rare variants. We first constructed risk prediction models, such as stepwise linear regression, least absolute shrinkage and selection operator, Elastic-Net and support vector machine. We then compared prediction accuracy by calculating the area under the curve. Our results show that the performance using both common and rare variants was better than using either the common variants only or the rare variants only.
INTRODUCTION
The success of genome-wide association studies (GWAS) has resulted in identification of many disease-related common genetic variants. Recently, by the development and application of the next generation sequencing (NGS) technology, many disease-related rare variants were also identified. There have been several attempts to build risk prediction models using these genetic variants such as single nucleotide polymorphisms (SNPs). Utilization of genetic variants was shown to improve risk prediction [1] . However, there were some problems to be solved in making the risk prediction model using genetic variants. First, there is the "large p small n" problem. This means that there are typically a larger number of genetic variants than the number of individuals. Second, because of linkage disequilibrium (LD) between genetic variants, statistical power drops in identifying significant association [2] .
Recently, various statistical approaches have been proposed to solve these problems. Penalized methods such as ridge [3] [4] [5] , least absolute shrinkage and selection operator (LASSO) [6] and Elastic-Net (EN) [7] have been proposed to solve the "large p small n" problem. The approach of penalized method in high dimensional data has more advantages than non-penalized methods in selecting genetic variants. In addition, data mining approaches have been widely used to improve the risk prediction performance. In particular, support vector machine (SVM) [8, 9] has been shown to have a good performance in prediction using a large number of SNPs [10] .
Most of these prediction models have used the common variants. However, while there are many reasons for small effect size of the common variant, one of them is missing heritability [11] . On the other hand, recent studies suggest that rare variants play an important role in the complex diseases having large effect sizes. From an evolutionary standpoint, rare variants are more harmful than common variants because they are under less negative selective pressures [12] .
In this study, we focus on risk prediction using both common and rare variants. We have systematically compared the performance of prediction models using real whole exome sequencing (WES) data from Type 2 Diabetes Genetic Exploration by Next-generation sequencing in multi-Ethnic Samples (T2D GENES) consortium. We compared the performances of three different risk prediction models based on common variants only, rare variants only, and both common and rare variants. We first constructed commonly used risk prediction methods, such as SLR, LASSO, EN and SVM. We then calculated the area under the curve (AUC) values of T2D prediction models to compare their performance. Our study showed that the SVM prediction model with LASSO selected variables yielded the largest AUC value.
II. MATERIAL
T2D-GENES consortium is a large scale collaborative study to find genetic variants that affect the risk of T2D. Deep exome sequencing data of 12,940 individuals were collected from five ancestry groups (Europeans, East Asians, South Asians, American Hispanics, and African Americans) [13] . Our study was conducted using 1,087 Korean samples from T2D-GENES consortium data. A total of 2,892,490 genetic variants are used for analysis after applying the quality control (QC) criteria of Hardy-Weinberg equilibrium (HWE) P-values < 10 -6 and gene call rate > 95%. Demographic information is summarized in Table 1 . 
III. METHODOLOGY
The common variants were selected from the data base on single-SNP analysis and from GWAS catalog [14] . The rare variants were then selected from the gene based analysis with Combined Multivariate and Collapsing (CMC) method [15] . Next, we constructed risk prediction models from each set of SNPs combinations using 5-fold cross-validation (CV). The data was randomly split into 5 CV sets, then training set was made with 4 CV sets and test set was made with the other CV set. At step 1, we selected the variants by using the SLR, LASSO and EN. At step 2, we then built the risk prediction models by using the SLR, LASSO, EN and SVM.
A. Variants combinations
First, we collected the common variants registered in GWAS catalog for T2D. Second, the common variants were selected by single-SNP analysis using a logistic regression with adjustment for sex and BMI. We chose the SNPs based on the P-values (1.0 × 10 3 ). The rare variants are first collapsed based on the CMC method and weighted CMC method. We then performed gene-based analysis using a logistic regression with adjustment for sex and BMI. We chose the genes based on the P-values (1.0 × 10 2 ). For rare variants selection, we considered four rare variant sets based on minor allele frequency (MAF) and functional annotation. We mapped variants to transcripts in Ensembl 66 (GRCh37.66). Table 2 summarizes four rare variant sets. Including both common and rare variants, we considered the following eight combinations of variants:
COM (Single-SNP analysis) COM-GWAS (GWAS catalog + Single-SNP analysis) RARE1 (collapsed rare variants by CMC method) RARE2 (collapsed rare variants by weighted CMC method) ALL1 (Single-SNP analysis + collapsed rare variants by CMC method) ALL2 (Single-SNP analysis + collapsed rare variants by weighted CMC method) TABLE 2 SUMMARY FOR RARE VARIANT SETS ptv: protein truncating variant set (nonsense, frameshift, essential splice site) using annotations from CHAoS v0.6.3, SnpEFF v3.1, and VEP v2.7 ptv_ms: protein-altering variant set (missense, inframeshift, non-essential splice site) in at least one mapped transcript with MAF<1% ptv_ns_b: subsets of missense variants with MAF<1%, predicted as deleterious by at least one of the five algorithms (Five algorithm: Polyphen2-HumDiv, PolyPhen2-HumVar, LRT, Mutation Taster, and SIFT) ptv_ns_s: Identify subsets of missense variants with MAF<1%, predicted as deleterious by all five algorithms ALL1-GWAS (GWAS catalog + Single-SNP analysis + collapsed rare variants by CMC method) ALL2-GWAS (GWAS catalog + Single-SNP analysis + collapsed rare variants by weighted CMC method)
B. Varialbe selection
In the T2D data, we selected SNPs using 5-fold CV on the training set. In this case, we used SLR, LASSO and EN to select SNPs. The phenotype yi of subject i = 1, ..., n was set as a dependent variable (T2D = 1, normal = 0), and the genotype xij of the j-th SNP (j = 1, ..., p) for subject i as an independent variables with an additive genetic model (AA = 0, Aa = 1, aa=2, where A and a indicate the major and minor allele, respectively). The SLR model is given by [16] using R package, named "MASS" [17] . The LASSO and EN estimates of were obtained by minimizing
respectively. The tuning parameters 1 2 are estimated using 10-fold CV. The penalized methods were performed using R package, named "glmnet" [18] .
C. Model prediction
To build a risk prediction model, we considered seven prediction models. The four models were constructed by using SLR, LASSO, EN and SVM. The other three models, SLR-SVM, LASSO-SVM and EN-SVM, were constructed by using SVM after selecting the variables via SLR, LASSO and EN. By combining eight variants combinations, we considered 56 combination of variable selection and prediction models. To compare the performance of these prediction models, we calculated the AUCs by applying each risk prediction models using the test set.
IV. RESULT Table 3 shows the prediction results with the AUC values for the test data sets. First, the case when using the SVM prediction model showed the largest AUC value of 0.8961 in ptv set with ALL2 group. Second, the case when using the SVM prediction model with LASSO selected variables generated the largest AUC value of 0.9291 in ptv_ms set with ALL1 group. Third, the case when using the SVM prediction model showed the largest AUC value of 0.8924 in ptv_ns_b set with ALL2 group. Lastly, the case when using the SVM prediction model showed the largest AUC value of 0.8961 in ptv_ns_s set with ALL2 group. The case when using the SVM prediction model with LASSO selected variables yielded the largest AUC value of 0.9291 in all groups.
In summary, the prediction performance using both common variants and rare variants is better than using only common variants or only rare variants. The ptv_ms set yielded the highest AUC value among the four rare variant sets.
V. DISCUSSION
In this study, we used statistical methods (SLR, LASSO, EN and SVM) to build risk prediction models. Then, we compared the performance of the risk prediction models by AUC. As a result, the performance of the risk prediction models using ptv_ms rare variant set was better than that of the prediction models using other rare variant sets. In the model building, SVM showed better performance than other methods. The performance of the risk prediction model is better than not using the SNPs reported in the GWAS catalog. For the further research, we plan to perform analysis with other continuous traits such as BMI and metabolic syndrome related traits. 
